CA2925690A1 - A bioreabsorbable composition containing antibacterial agents for the treatment of lower back pain - Google Patents

A bioreabsorbable composition containing antibacterial agents for the treatment of lower back pain Download PDF

Info

Publication number
CA2925690A1
CA2925690A1 CA2925690A CA2925690A CA2925690A1 CA 2925690 A1 CA2925690 A1 CA 2925690A1 CA 2925690 A CA2925690 A CA 2925690A CA 2925690 A CA2925690 A CA 2925690A CA 2925690 A1 CA2925690 A1 CA 2925690A1
Authority
CA
Canada
Prior art keywords
weight
composition
hydrogel
composition according
back pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2925690A
Other languages
English (en)
French (fr)
Inventor
Davide Cremascoli
Carlo Luca Romano'
Enzo Meani
Edgardo Cremascoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novagenit Srl
Mero Srl
Original Assignee
Novagenit Srl
Mero Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novagenit Srl, Mero Srl filed Critical Novagenit Srl
Publication of CA2925690A1 publication Critical patent/CA2925690A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2925690A 2013-10-21 2014-10-20 A bioreabsorbable composition containing antibacterial agents for the treatment of lower back pain Abandoned CA2925690A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2013A001755 2013-10-21
IT001755A ITMI20131755A1 (it) 2013-10-21 2013-10-21 Composizione bioriassorbibile contenente agenti antibatterici per il trattamento del dolore lombare
PCT/IB2014/065471 WO2015059623A1 (en) 2013-10-21 2014-10-20 A bioreabsorbable composition containing antibacterial agents for the treatment of lower back pain

Publications (1)

Publication Number Publication Date
CA2925690A1 true CA2925690A1 (en) 2015-04-30

Family

ID=49640024

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2925690A Abandoned CA2925690A1 (en) 2013-10-21 2014-10-20 A bioreabsorbable composition containing antibacterial agents for the treatment of lower back pain

Country Status (7)

Country Link
JP (1) JP2016533354A (it)
CN (1) CN105682640A (it)
AU (1) AU2014338592A1 (it)
CA (1) CA2925690A1 (it)
IL (1) IL245164A0 (it)
IT (1) ITMI20131755A1 (it)
WO (1) WO2015059623A1 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
WO2017065245A1 (ja) * 2015-10-13 2017-04-20 学校法人 慶應義塾 椎間板変性症、腰痛改善を処置するための医薬組成物、及び治療薬のスクリーニング方法
EP4378535A3 (en) * 2016-11-16 2024-06-12 Persica Pharmaceuticals Ltd. Antibiotic formulations for lower back pain
RU2737380C2 (ru) * 2017-04-24 2020-11-27 Общество с ограниченной ответственностью "ФБК" Комбинированное средство для внутрисуставного введения
JP7251813B2 (ja) * 2017-11-16 2023-04-04 ペルシカ ファーマシューティカルズ リミテッド リネゾリド製剤
WO2020064844A1 (en) * 2018-09-26 2020-04-02 Ascendis Pharma A/S Treatment of infections
CN113134116B (zh) * 2020-01-20 2022-09-06 山东威高宏瑞医学科技有限公司 内镜微创手术用的填充组合物及填充制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05970A (ja) * 1991-06-25 1993-01-08 Sumitomo Cement Co Ltd 骨ずい炎治療剤
WO2007050744A2 (en) * 2005-10-26 2007-05-03 Biocure, Inc. Hydrogel spinal disc implants with swellable articles
EP2213315A1 (en) * 2009-01-30 2010-08-04 Mero S.r.L. Antibacterial hydrogel and use thereof in orthopedics
WO2011082390A2 (en) * 2010-01-02 2011-07-07 Yeung Jeffrey E Internal and external disc shunts alleviate back pain
IT1401498B1 (it) * 2010-07-30 2013-07-26 Mero Srl Idrogelo a base di acido ialuronico e suo uso in ortopedia

Also Published As

Publication number Publication date
JP2016533354A (ja) 2016-10-27
WO2015059623A1 (en) 2015-04-30
ITMI20131755A1 (it) 2015-04-22
AU2014338592A1 (en) 2016-04-21
IL245164A0 (en) 2016-06-30
CN105682640A (zh) 2016-06-15

Similar Documents

Publication Publication Date Title
CA2925690A1 (en) A bioreabsorbable composition containing antibacterial agents for the treatment of lower back pain
Schaer et al. Hydrophobic polycationic coatings that inhibit biofilms and support bone healing during infection
Diefenbeck et al. Gentamicin coating of plasma chemical oxidized titanium alloy prevents implant-related osteomyelitis in rats
EP2391399B1 (en) Antibacterial hydrogel and use thereof in orthopedics
EP2598180B1 (en) Hyaluronic acid based hydrogel and use thereof in surgery
Kenley et al. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein‐2 (rhBMP‐)
US20140220142A1 (en) Composition for bone regeneration
Mäkinen et al. Efficacy of bioabsorbable antibiotic containing bone screw in the prevention of biomaterial-related infection due to Staphylococcus aureus
Jayasuriya et al. Fabrication and characterization of novel hybrid organic/inorganic microparticles to apply in bone regeneration
Kim et al. Osteochondral and bone tissue engineering scaffold prepared from Gallus var domesticus derived demineralized bone powder combined with gellan gum for medical application
WO2007064304A1 (en) Biocompatible composition and uses thereof
AU2014204104A1 (en) Compositions comprising citrate and applications thereof
Lin et al. Augmentation of osseous phenotypes in vivo with a synthetic peptide
Bottagisio et al. Vancomycin-nanofunctionalized peptide-enriched silk fibroin to prevent methicillin-resistant Staphylococcus epidermidis-induced femoral nonunions in rats
Zhou et al. Efficacy of tobramycin-loaded coating K-wire in an open-fracture rabbit model contaminated by staphylococcus aureus
Oh et al. Prolonged anti-bacterial activity of ion-complexed doxycycline for the treatment of osteomyelitis
US20220378980A1 (en) Composite demineralized bone matrix composition containing bone mineral component and method for producing same
WAHJUNINGRUM et al. Cytotoxicity of chitosan derived from shrimp for bone scaffold on adipose tissue-derived mesenchymal stem cells
RU2811281C1 (ru) Способ лечения хронического остеомиелита
Dewi et al. The newly bone formation with carbonate apatite-chitosan bone substitute in the rat tibia
KR102416859B1 (ko) 골 무기질 성분을 함유하는 복합 탈회골 조성물 및 그 제조공정
EP3570868B1 (en) Synthetic antimicrobial peptides and their applications for the treatment and prevention of musculoskeletal infections
Fralish Generation of Gelatin-Based Antibiotic-Eluting Conjugates for the Prevention of Surgical Site Infections
Zimmerli Orthopaedic Implant–Associated Infections: Pathogenesis, Clinical Presentation and Management
TR2022012983A2 (tr) Kemi̇k rahatsizliklari ve/veya kirilmalari i̇çi̇n onarici ve tedavi̇ edi̇ci̇ özelli̇kte bi̇youyumlu bi̇r ürün ve söz konusu ürünün eldesi̇ i̇çi̇n bi̇r yöntem

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190716

FZDE Discontinued

Effective date: 20211221